Neal Walker Aclaris Therapeutics, Inc. (ACRS) insider trading activity
Neal Walker is CEO of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 1.47 Million shares of ACRS, which is worth approximately $2.68 Million. The most recent transaction as insider was on Mar 01, 2025, when has been sold 3,277 shares (Common Stock) at a price of $1.99 per share, resulting in proceeds of $6,521. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.47M
2.32%
3M change
14.65%
12M change
Total Value Held
$2.68 Million
Neal Walker Transaction History
Also insider at
NW
Neal Walker
CEO
Wayne, PA